Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
  • USCOM Ltd

    Development, design, manufacture, and marketing of non-invasive cardiovascular and pulmonary medical devices.

    UCM$0.023
     -0.001 -4.17%

    Data last updated:May 15, 2024 – 2.23pm. Data is 20 mins delayed.

    Previous Close

    0.024

    Open

    0.024

    Day Range

    0.023 - 0.024

    52 Week Range

    0.023 - 0.054

    Volume

    57,851

    Value

    1,373

    Bid

    0.023

    Ask

    0.030

    Dividend Yield

    0.00%

    P/E Ratio

    0.00

    Market Cap

    5.626M

    Total Issue

    244,587,610

    ASX Announcements

    Market Sensitive

    Quarterly Activities/Appendix 4C Cash Flow Report

    CTE – Third Quarter Cashflow Report, CTE - Third Quarter Activity Report

    • Apr 24, 2024
    • 7 pages

    Change in substantial holding - Phillips

    Change in substantial holding

    • Mar 5, 2024
    • 3 pages

    Change of Director's Interest Notice - Phillips

    Change of Director’s Interest Notice

    • Mar 5, 2024
    • 3 pages

    Application for quotation of securities - UCM

    Appendix 2A (Application for Quotation of Securities)

    • Mar 5, 2024
    • 6 pages

    Change in substantial holding - Jetan

    Change in substantial holding

    • Mar 4, 2024
    • 2 pages

    View all UCM announcements

    March 2020

    Uscom CEO Rob Phillips with the Uscom 1A device, which is being used in China to monitor the health of patients with severe cases of the coronavirus.

    Healthcare small caps Uscom and Zoono boom on coronavirus outbreak

    Uscom's technology is being used to monitor critically ill coronavirus patients in China, while Zoono's "microbe shield" has been proved to kill the virus.

    • Yolanda Redrup

    January 2017

    Medical device maker USCOM has China in focus as it nears profitability

    A $65 million contract with a state-owned enterprise has pushed medical device maker USCOM to a record quarter of manufacturing.

    • Updated
    • Jessica Gardner

    October 2015

    Uscom aiming for $20m revenue in FY20

    The company is only at the beginning of this growth curve.

    • Updated
    • Elise Shaw

    November 2014

    How a ‘sock and sandal wearing academic’ is bringing medical device maker USCOM back to life

    Rob Phillips has steered cardiac monitoring company USCOM through two near death experiences. But now, two years after dramatically regaining control of the company he founded, Mr Phillips reckons the changes he has put in place could finally generate a profit.

    • Jessica Gardner

    November 2009

    Brief: Uscom

    Corporate snapshot for Uscom

    April 2005

    Global Wind Partners tracking well

    Uscom has highlighted the potential market for non-invasive heart diagnostics and recently received FDA approval for its product. It is not the only player in the space, with a potential float of Atcor Medical also on the agenda.

    • MARTIN PRETTY mpretty@afr.com.au

    Copyright © 2024. Company information displayed on The Australian Financial Review is sourced from Morningstar and ASX and is subject to their terms and conditions as set out in our Terms of Use. The Australian Financial Review does not accept any responsibility for the accuracy and/or completeness of such data or information.